Similar regulatory mechanisms may drive PA EC calcification in different types of PH, and PAH patients with BMPR2 mutations or BMP signaling pathway impairments (104) would be expected to be specifically vulnerable in this scenario given the association of impaired BMPR2 signaling with EndoMT (211). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.